Immunogenicity of a Two-Dose Human Papillomavirus Vaccine Schedule in HIV-Infected Adolescents with Immune Reconstitution
HIV-infected patients are at increased risk of human papillomavirus (HPV) acquisition and HPV-associated diseases. This study set out to determine whether a two-dose (2D) HPV vaccination schedule was sufficient in HIV-infected adolescents with immune reconstitution (IR) following antiretroviral trea...
Saved in:
Main Authors: | , , , , , , , , , , , , |
---|---|
Other Authors: | |
Format: | Article |
Published: |
2022
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/74194 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
id |
th-mahidol.74194 |
---|---|
record_format |
dspace |
spelling |
th-mahidol.741942022-08-04T11:49:31Z Immunogenicity of a Two-Dose Human Papillomavirus Vaccine Schedule in HIV-Infected Adolescents with Immune Reconstitution Supattra Rungmaitree Charin Thepthai Zheng Quan Toh Noppasit Musiwiraphat Alan Maleesatharn Rattanachai Rermruay Sathida Sungkate Wanatpreeya Phongsamart Keswadee Lapphra Orasri Wittawatmongkol Tararaj Dharakul Kim Mulholland Kulkanya Chokephaibulkit Siriraj Hospital London School of Hygiene & Tropical Medicine University of Melbourne Bhumibol Adulyadej Hospital Maharaj Nakhon Ratchasima Hospital Murdoch Children's Research Institute Immunology and Microbiology Medicine Pharmacology, Toxicology and Pharmaceutics HIV-infected patients are at increased risk of human papillomavirus (HPV) acquisition and HPV-associated diseases. This study set out to determine whether a two-dose (2D) HPV vaccination schedule was sufficient in HIV-infected adolescents with immune reconstitution (IR) following antiretroviral treatment. Participants aged 9–15 years who had CD4 cell counts > 500 cells/mm3 and HIV-1 RNA < 40 copies/mL for at least one year were assigned to the 2D schedule, while older participants or those without IR received a three-dose (3D) schedule. Antibodies to HPV-16 and-18 were measured using a pseudovirion-based neutralization assay. A total of 96 subjects were enrolled; 31.3% and 68.7% received the 2D and 3D schedule, respectively. Of these, 66.7% and 57.6% of the 2D and 3D participants, respectively, were male. The seroconversion rates for HPV-16 and HPV-18 were 100% in all cases, except for HPV-18 in males who received the 3D schedule (97.4%). In males, the anti-HPV-16 geometric mean titers (GMTs) were 6859.3 (95% confidence interval, 4394.3–10,707.1) and 7011.1 (4648.8–10,573.9) in the 2D and 3D groups (p = 0.946), respectively, and the anti-HPV-18 GMTs were 2039.3 (1432.2–2903.8) and 2859.8 (1810.0–4518.4) in the 2D and 3D (p = 0.313) groups, respectively. In females, the anti-HPV-16 GMTs were 15,758.7 (8868.0–28,003.4) and 26,241.6 (16,972.7–40,572.3) in the 2D and 3D groups (p = 0.197), respectively, and the anti-HPV-18 GMTs were 5971.4 (3026.8–11,780.6) and 9993.1 (5950.8–16,781.1) in the 2D and 3D groups (p = 0.271), respectively. In summary, a 2D schedule is as immunogenic in young adolescents with IR as a 3D schedule in older subjects and those without IR. 2022-08-04T04:10:34Z 2022-08-04T04:10:34Z 2022-01-01 Article Vaccines. Vol.10, No.1 (2022) 10.3390/vaccines10010118 2076393X 2-s2.0-85123257357 https://repository.li.mahidol.ac.th/handle/123456789/74194 Mahidol University SCOPUS https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85123257357&origin=inward |
institution |
Mahidol University |
building |
Mahidol University Library |
continent |
Asia |
country |
Thailand Thailand |
content_provider |
Mahidol University Library |
collection |
Mahidol University Institutional Repository |
topic |
Immunology and Microbiology Medicine Pharmacology, Toxicology and Pharmaceutics |
spellingShingle |
Immunology and Microbiology Medicine Pharmacology, Toxicology and Pharmaceutics Supattra Rungmaitree Charin Thepthai Zheng Quan Toh Noppasit Musiwiraphat Alan Maleesatharn Rattanachai Rermruay Sathida Sungkate Wanatpreeya Phongsamart Keswadee Lapphra Orasri Wittawatmongkol Tararaj Dharakul Kim Mulholland Kulkanya Chokephaibulkit Immunogenicity of a Two-Dose Human Papillomavirus Vaccine Schedule in HIV-Infected Adolescents with Immune Reconstitution |
description |
HIV-infected patients are at increased risk of human papillomavirus (HPV) acquisition and HPV-associated diseases. This study set out to determine whether a two-dose (2D) HPV vaccination schedule was sufficient in HIV-infected adolescents with immune reconstitution (IR) following antiretroviral treatment. Participants aged 9–15 years who had CD4 cell counts > 500 cells/mm3 and HIV-1 RNA < 40 copies/mL for at least one year were assigned to the 2D schedule, while older participants or those without IR received a three-dose (3D) schedule. Antibodies to HPV-16 and-18 were measured using a pseudovirion-based neutralization assay. A total of 96 subjects were enrolled; 31.3% and 68.7% received the 2D and 3D schedule, respectively. Of these, 66.7% and 57.6% of the 2D and 3D participants, respectively, were male. The seroconversion rates for HPV-16 and HPV-18 were 100% in all cases, except for HPV-18 in males who received the 3D schedule (97.4%). In males, the anti-HPV-16 geometric mean titers (GMTs) were 6859.3 (95% confidence interval, 4394.3–10,707.1) and 7011.1 (4648.8–10,573.9) in the 2D and 3D groups (p = 0.946), respectively, and the anti-HPV-18 GMTs were 2039.3 (1432.2–2903.8) and 2859.8 (1810.0–4518.4) in the 2D and 3D (p = 0.313) groups, respectively. In females, the anti-HPV-16 GMTs were 15,758.7 (8868.0–28,003.4) and 26,241.6 (16,972.7–40,572.3) in the 2D and 3D groups (p = 0.197), respectively, and the anti-HPV-18 GMTs were 5971.4 (3026.8–11,780.6) and 9993.1 (5950.8–16,781.1) in the 2D and 3D groups (p = 0.271), respectively. In summary, a 2D schedule is as immunogenic in young adolescents with IR as a 3D schedule in older subjects and those without IR. |
author2 |
Siriraj Hospital |
author_facet |
Siriraj Hospital Supattra Rungmaitree Charin Thepthai Zheng Quan Toh Noppasit Musiwiraphat Alan Maleesatharn Rattanachai Rermruay Sathida Sungkate Wanatpreeya Phongsamart Keswadee Lapphra Orasri Wittawatmongkol Tararaj Dharakul Kim Mulholland Kulkanya Chokephaibulkit |
format |
Article |
author |
Supattra Rungmaitree Charin Thepthai Zheng Quan Toh Noppasit Musiwiraphat Alan Maleesatharn Rattanachai Rermruay Sathida Sungkate Wanatpreeya Phongsamart Keswadee Lapphra Orasri Wittawatmongkol Tararaj Dharakul Kim Mulholland Kulkanya Chokephaibulkit |
author_sort |
Supattra Rungmaitree |
title |
Immunogenicity of a Two-Dose Human Papillomavirus Vaccine Schedule in HIV-Infected Adolescents with Immune Reconstitution |
title_short |
Immunogenicity of a Two-Dose Human Papillomavirus Vaccine Schedule in HIV-Infected Adolescents with Immune Reconstitution |
title_full |
Immunogenicity of a Two-Dose Human Papillomavirus Vaccine Schedule in HIV-Infected Adolescents with Immune Reconstitution |
title_fullStr |
Immunogenicity of a Two-Dose Human Papillomavirus Vaccine Schedule in HIV-Infected Adolescents with Immune Reconstitution |
title_full_unstemmed |
Immunogenicity of a Two-Dose Human Papillomavirus Vaccine Schedule in HIV-Infected Adolescents with Immune Reconstitution |
title_sort |
immunogenicity of a two-dose human papillomavirus vaccine schedule in hiv-infected adolescents with immune reconstitution |
publishDate |
2022 |
url |
https://repository.li.mahidol.ac.th/handle/123456789/74194 |
_version_ |
1763497425946804224 |